These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21673355)

  • 81. Cervical cancer screening and prevention in low-resource settings.
    Bradford L; Goodman A
    Clin Obstet Gynecol; 2013 Mar; 56(1):76-87. PubMed ID: 23337844
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
    Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
    Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
    Xu QX; Zhang ZY
    Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
    [TBL] [Abstract][Full Text] [Related]  

  • 87. How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age?
    de Kok IM; van Rosmalen J; Rozemeijer K; Penning C; van Ballegooijen M
    Int J Cancer; 2014 Jan; 134(2):460-6. PubMed ID: 23824905
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Methods of cervical cancer screening and facing new problems in China].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
    [No Abstract]   [Full Text] [Related]  

  • 89. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
    Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
    BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cervical cytology screening in teens.
    Moscicki AB
    Curr Womens Health Rep; 2003 Dec; 3(6):433-7. PubMed ID: 14613663
    [TBL] [Abstract][Full Text] [Related]  

  • 91. HPV primary screening for cervical cancer: more pain than protection.
    Davey DD; Armenti CA
    Diagn Cytopathol; 2000 Jun; 22(6):333-5. PubMed ID: 10820524
    [No Abstract]   [Full Text] [Related]  

  • 92. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.
    Luyten A; Buttmann-Schweiger N; Luyten K; Mauritz C; Reinecke-Lüthge A; Pietralla M; Meijer CJ; Petry KU
    Int J Cancer; 2014 Sep; 135(6):1408-16. PubMed ID: 24519782
    [TBL] [Abstract][Full Text] [Related]  

  • 93. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.
    Snijders PJ; Verhoef VM; Arbyn M; Ogilvie G; Minozzi S; Banzi R; van Kemenade FJ; Heideman DA; Meijer CJ
    Int J Cancer; 2013 May; 132(10):2223-36. PubMed ID: 22907569
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
    Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
    J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.
    Scarinci IC; Litton AG; Garcés-Palacio IC; Partridge EE; Castle PE
    Womens Health Issues; 2013; 23(2):e123-30. PubMed ID: 23410619
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Single life time cytological screening in high risk women as an economical and feasible approach to control cervical cancer in developing countries like India.
    Misra JS; Srivastava AN; Das V
    Asian Pac J Cancer Prev; 2015; 16(3):859-62. PubMed ID: 25735373
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cost-effectiveness of new cytology technologies.
    Hutchinson M; Farber FL
    Am J Clin Pathol; 2000 Jan; 113(1):149-51. PubMed ID: 10631869
    [No Abstract]   [Full Text] [Related]  

  • 98. Impact of GP reminders on follow-up of abnormal cervical cytology: a before-after study in Danish general practice.
    Kristiansen BK; Andersen B; Bro F; Svanholm H; Vedsted P
    Br J Gen Pract; 2017 Aug; 67(661):e580-e587. PubMed ID: 28716995
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication.
    Leung SMK; Wu J; Chan KKL; Jit M
    Hong Kong Med J; 2023 Aug; 29 Suppl 4(4):11-15. PubMed ID: 37690800
    [No Abstract]   [Full Text] [Related]  

  • 100. Silent killer of the night: a feasibility study of an outreach well-women clinic for cervical cancer screening in female sex workers in Hong Kong.
    Wong WC; Wun YT; Chan KW; Liu Y
    Int J Gynecol Cancer; 2008; 18(1):110-5. PubMed ID: 17466035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.